Cargando…
Endostatin Polymorphism 4349G/A(D104N) is not Associated with Aggressiveness of Disease in Postate Cancer
Endostatin is an important inhibitory molecule which mediates the sequential steps involved in angiogenesis. Lower level or impaired function of endostatin is associated with a higher risk of developing malignant solid tumors and with a worse prognosis of the disease. The endostatin N104 polymorphis...
Autores principales: | Li, He Cheng, Cai, Qiu Yin, Shinohara, Eric T., Cai, Hui, Cao, Carolyn, Fei Wang, Zuo, Teng, Ming, Zheng, Wei, Lu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851366/ https://www.ncbi.nlm.nih.gov/pubmed/15735323 http://dx.doi.org/10.1155/2005/650109 |
Ejemplares similares
-
Endostatin Polymorphism 4349G/A(D104N) Is not Associated with Aggressiveness of Disease in Prostate Cancer
por: Li, He Cheng, et al.
Publicado: (2005) -
MRI imaging of prenatal-postatal brain malformations
por: Vegar-Zubović, Sandra, et al.
Publicado: (2021) -
4349 Survey of Regulatory Reforms to Address Comprehension of Clinical Trial Results
por: Kirkland, Matthieu, et al.
Publicado: (2020) -
A high risk of osteosarcoma in individuals who are homozygous for the p.D104N in endostatin
por: Bi, Wen-Zhi, et al.
Publicado: (2015) -
Genotype analysis of the human endostatin variant p.D104N in benign and malignant adrenocortical tumors
por: de Paula Mariani, Beatriz Marinho, et al.
Publicado: (2012)